John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$251M |
| 2 |
Eli Lilly
LLY
|
+$246M |
| 3 |
Cisco
CSCO
|
+$226M |
| 4 |
Chevron
CVX
|
+$224M |
| 5 |
Mastercard
MA
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$262M |
| 2 |
XYZ
Block Inc
XYZ
|
+$236M |
| 3 |
Target
TGT
|
+$228M |
| 4 |
TJX Companies
TJX
|
+$222M |
| 5 |
Roku
ROKU
|
+$221M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 15.24% |
| 3 | Consumer Discretionary | 8.56% |
| 4 | Financials | 8.41% |
| 5 | Industrials | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
CALL
Humana
HUM
$46B
| $10.7M | 0.02% |
27,600
+21,400
| +345% | +$9.08M |
|
727
Angi Inc
ANGI
$200M
| $10.7M | 0.02% |
87,005
+16,461
| +23% | +$1.89M |
|
728
CALL
Alibaba
BABA
$286B
| $10.7M | 0.02% |
72,500
-58,500
| -45% | -$10.6M |
|
729
Pitney Bowes
PBI
$2.25B
| $10.7M | 0.02% |
1,488,257
+895,725
| +151% | +$7.01M |
|
|
730
Target
TGT
$77.4B
| $10.7M | 0.02% |
46,841
-908,694
| -95% | -$228M |
|
|
X
731
PUT
DELISTED
US Steel
X
| $10.7M | 0.02% |
487,700
+165,500
| +51% | +$4.14M |
|
732
CALL
Dow Inc
DOW
$22.8B
| $10.7M | 0.02% |
+186,100
| New | +$11.4M |
|
733
PUT
Wynn Resorts
WYNN
$10.3B
| $10.7M | 0.02% |
126,400
+90,200
| +249% | +$8.9M |
|
734
PUT
Visa
V
$711B
| $10.6M | 0.02% |
47,800
-44,900
| -48% | -$10.5M |
|
735
State Street SPDR S&P Biotech ETF
XBI
$11.4B
| $10.6M | 0.02% |
84,396
-88,804
| -51% | -$11.4M |
|
|
FOLD
736
DELISTED
Amicus Therapeutics
FOLD
| $10.6M | 0.02% |
1,109,969
+480,388
| +76% | +$4.91M |
|
737
Zentalis Pharmaceuticals
ZNTL
$363M
| $10.6M | 0.02% |
158,976
+30,105
| +23% | +$1.74M |
|
738
Ionis Pharmaceuticals
IONS
$10.1B
| $10.5M | 0.02% |
314,134
+7,646
| +2% | +$288K |
|
739
BGC Group
BGC
$5.58B
| $10.5M | 0.02% |
2,015,880
+1,092,733
| +118% | +$5.8M |
|
740
FirstService
FSV
$6.34B
| $10.5M | 0.02% |
58,183
+6,287
| +12% | +$1.16M |
|
741
Cognizant
CTSH
$27.9B
| $10.5M | 0.02% |
141,493
-928,288
| -87% | -$68.5M |
|
742
PUT
Autodesk
ADSK
$53.5B
| $10.4M | 0.02% |
36,600
+14,300
| +64% | +$4.38M |
|
|
EGLE
743
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $10.4M | 0.02% |
206,834
+43,981
| +27% | +$1.99M |
|
744
Sundial Growers
SNDL
$343M
| $10.4M | 0.02% |
1,537,680
+852,982
| +125% | +$6.66M |
|
745
PUT
Kimberly-Clark
KMB
$37B
| $10.4M | 0.02% |
78,600
-20,200
| -20% | -$2.75M |
|
746
Companhia Siderúrgica Nacional
SID
$1.35B
| $10.3M | 0.02% |
1,966,625
+734,525
| +60% | +$5.52M |
|
747
Community Health Systems
CYH
$423M
| $10.3M | 0.02% |
883,816
-299,626
| -25% | -$3.91M |
|
|
TPH
748
DELISTED
Tri Pointe Homes
TPH
| $10.3M | 0.02% |
+491,503
| New | +$11.1M |
|
749
CALL
Apple
AAPL
$4.55T
| $10.3M | 0.02% |
73,000
-726,700
| -91% | -$107M |
|
|
X
750
CALL
DELISTED
US Steel
X
| $10.3M | 0.02% |
466,900
+197,300
| +73% | +$4.94M |
|
Similar funds
John Overdeck's Q3 2021 Portfolio in Review
As of Q3 2021, John Overdeck held 4,966 positions worth $44.7B, up 1.5% from $44.1B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
John Overdeck deployed $1.71B of net new capital in Q3 2021, opening 996 new positions and adding to 1,597 existing holdings. Its largest new stake was PayPal: 884,227 shares worth $230M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Block Inc, an estimated $236M trimmed.
- John Overdeck's largest Q3 2021 buy was PayPal: 884,227 shares worth $230M.
- John Overdeck added most to Cisco in Q3 2021, an estimated $226M increase.
- John Overdeck's biggest Q3 2021 reduction was Block Inc, cutting an estimated $236M.
- John Overdeck fully exited Pfizer in Q3 2021, selling an estimated $262M.
- John Overdeck's ten largest holdings make up 5.2% of its $44.7B portfolio in Q3 2021.
- John Overdeck opened 996 new positions and closed 790 in Q3 2021.
- John Overdeck's portfolio value rose 1.5% quarter-over-quarter to $44.7B.
Based on Two Sigma Investments's 13F filing for Q3 2021, filed 15 Nov 2021.